Earnings Presentation on Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2025
Awaiting price reaction for this filing.
Rainbow Children's Medicare submitted its Q4 FY25 and full-year FY25 earnings presentation to the exchanges. For Q4 FY25, revenue grew 8.5% YoY to ₹3,701 Mn, EBITDA rose 8.7% to ₹1,147 Mn, and PAT increased 10.7% to ₹566 Mn. For full-year FY25, revenue grew 16.9% YoY to ₹15,159 Mn, EBITDA grew 14.2% to ₹4,899 Mn, and PAT grew 11.9% to ₹2,442 Mn. EBITDA margins, however, contracted to 32.3% (FY25) from 33.1% (FY24) and to 30.5% (Q4 FY25) from 30.9% (Q4 FY24). Operational metrics improved with occupancy rising to 50.5% (FY25) from 47.9% (FY24), and IP discharges and OP consultations both up 12% YoY. The company operates 19 hospitals across 6 cities with 1,935 beds and 910+ doctors. A multi-year expansion roadmap was outlined, adding 250 beds in FY25-26, 130 in FY26-27, and 400 in FY27-28, taking total capacity to 2,715 beds.
The strong double-digit revenue and PAT growth signals healthy demand, but margin compression and a sequential decline in Q4 revenue/EBITDA versus Q3 FY25 may temper near-term sentiment. The clear 3-year capacity expansion plan provides visibility on future growth, likely to be viewed positively by investors.